Voloridge Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-725,508	Closed	-$13.3M	–	1150
2024 Q4	$13.3M	Sell	725,508 -583,485	-45%	-$9.42M	0.05%	490
2024 Q3	$20.1M	Sell	1,308,993 -292,223	-18%	-$4.87M	0.07%	372
2024 Q2	$26M	Buy	1,601,216 +243,243	+18%	+$3.93M	0.1%	291
2024 Q1	$25.1M	Buy	1,357,973 +75,796	+6%	+$1.88M	0.09%	276
2023 Q4	$40.1M	Buy	1,282,177 +237,676	+23%	+$5.68M	0.16%	175
2023 Q3	$21.8M	Buy	1,044,501 +529,927	+103%	+$14.4M	0.11%	267
2023 Q2	$12.3M	Buy	514,574 +298,642	+138%	+$6.64M	0.06%	408
2023 Q1	$4.06M	Sell	215,932 -289,172	-57%	-$5.51M	0.02%	747
2022 Q4	$8.04M	Sell	505,104 -199,461	-28%	-$3.12M	0.04%	501
2022 Q3	$11.5M	Sell	704,565 -337,690	-32%	-$5.47M	0.06%	407
2022 Q2	$14.7M	Buy	1,042,255 +617,594	+145%	+$11.5M	0.08%	336
2022 Q1	$10.3M	Buy	424,661 +98,748	+30%	+$2.39M	0.06%	401
2021 Q4	$7.61M	Sell	325,913 -443,759	-58%	-$8.93M	0.04%	551
2021 Q3	$12.8M	Buy	769,672 +169,240	+28%	+$3.26M	0.08%	345
2021 Q2	$14.6M	Sell	600,432 -38,932	-6%	-$879K	0.1%	263
2021 Q1	$16.5M	Buy	+639,364	New	+$28.1M	0.12%	222
2019 Q4	–	Sell	-104,352	Closed	-$3.76M	–	1049
2019 Q3	$3.76M	Buy	104,352 +92,192	+758%	+$2.8M	0.07%	315
2019 Q2	$325K	Sell	12,160 -21,618	-64%	-$552K	0.01%	634
2019 Q1	$907K	Buy	+33,778	New	+$789K	0.03%	508